NOTCH1 Gene: Structure, Function, and Clinical Significance

A comprehensive overview of the NOTCH1 gene, its protein product, associated diseases, expression patterns, and mutations.

Gene Information Card

Symbol NOTCH1
Full Name Notch receptor 1
Gene Type Protein coding
Chromosomal Location 9q34.3
NCBI Gene ID 4851 ncbi.nlm.nih.gov/gene/4851
Ensembl ID ENSG00000148400
UniProt ID P46531
OMIM ID 190198
HGNC ID 7881
Aliases TAN1, hN1, AOS5, AOVD1, CADASIL2, NSBAD

Description

NOTCH1 encodes a member of the Notch family of transmembrane receptors. The protein is synthesized as a single precursor that is cleaved to form a heterodimer. Upon ligand binding, the receptor undergoes a series of proteolytic cleavages that release the intracellular domain (NICD), which translocates to the nucleus and regulates transcription. NOTCH1 signaling is critical for cell fate determination, proliferation, and apoptosis during development and adult tissue homeostasis. Mutations in NOTCH1 are associated with various cancers, particularly T-cell acute lymphoblastic leukemia (T-ALL), and developmental disorders such as Adams-Oliver syndrome and aortic valve disease.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
T-cell acute lymphoblastic leukemia (T-ALL) Activating mutations in the heterodimerization domain or PEST domain lead to increased NOTCH1 signaling, promoting oncogenesis. COSMIC; ClinVar; PMID: 15516921
Aortic valve disease (bicuspid aortic valve, calcific aortic stenosis) Loss-of-function mutations in NOTCH1 impair valve development and promote calcification. OMIM #109730; PMID: 15863673
Adams-Oliver syndrome Heterozygous loss-of-function mutations cause vascular and limb defects. OMIM #616028; PMID: 25557784
CADASIL-like small vessel disease Missense mutations in the EGF-like repeats lead to vascular smooth muscle cell degeneration. OMIM #616779; PMID: 25557784
Chronic lymphocytic leukemia (CLL) Recurrent NOTCH1 mutations (mostly PEST domain) are associated with poor prognosis. COSMIC; PMID: 21670405

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 8.9 Medium
Brain 6.2 Low
Lung 5.1 Low
Liver 4.3 Low
Kidney 7.0 Medium
Spleen 6.5 Low
Thymus 12.3 High
Bone Marrow 9.8 Medium
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 10.5 High expression
HeLa (cervical cancer) 7.2 Moderate
A549 (lung cancer) 6.8 Moderate
MCF7 (breast cancer) 5.9 Low
Jurkat (T-ALL) 15.0 Very high
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.4724T>C (p.Leu1575Pro) Missense Somatic in T-ALL Activates NOTCH1 signaling
c.7328C>T (p.Pro2443Leu) Missense Germline in Adams-Oliver syndrome Loss of function
c.6802C>T (p.Arg2268Cys) Missense Germline in CADASIL-like Aberrant protein aggregation
c.7541_7542delCT (p.Pro2514fs) Frameshift Somatic in CLL Truncated PEST domain, increased stability
Mutation functional classification

Loss of Function (LOF)

Mutations that reduce or abolish NOTCH1 signaling, often due to truncation or missense changes in critical domains, leading to developmental defects or tumor suppression loss.

Gain of Function (GOF)

Mutations that enhance NOTCH1 signaling, typically in the heterodimerization domain or PEST domain, leading to increased NICD stability and oncogenic activity.

Dominant Negative (DN)

Mutations that produce a receptor that interferes with wild-type NOTCH1 function, often seen in some missense mutations affecting ligand binding or cleavage.

Gene Ontology (GO)

• Notch binding • calcium ion binding
• receptor activity • transcription factor activity
• RNA polymerase II distal enhancer sequence-specific binding • cell fate determination
• positive regulation of transcription by RNA polymerase II • negative regulation of transcription by RNA polymerase II
• cell differentiation • apoptotic process
• angiogenesis

Pathways

Notch signaling pathway
Signaling by NOTCH1
Regulation of stem cell pluripotency
T-cell receptor signaling pathway
Hematopoietic cell lineage

Protein Summary

The NOTCH1 protein is a 2555-amino acid single-pass type I transmembrane receptor. It is synthesized as a 300 kDa precursor that is cleaved by furin into a 180 kDa N-terminal extracellular domain and a 120 kDa C-terminal transmembrane fragment, which remain non-covalently associated. The extracellular domain contains 36 EGF-like repeats and 3 LIN12/Notch repeats, while the intracellular domain includes a RAM domain, ankyrin repeats, a transactivation domain, and a PEST sequence. Ligand binding (e.g., Delta-like, Jagged) triggers two proteolytic cleavages (ADAM metalloprotease and gamma-secretase) that release the NICD, which translocates to the nucleus and forms a complex with RBPJ and MAML to activate transcription of target genes such as MYC and HES1.

Related Products

Product name Cat.No. Species Gene ID
NOTCH1 Knockout HEK293 Cell Line EDJ-KQ435 Human 4851 Details Get a Quote
NOTCH1 Knockout A-549 Cell Line EDJ-KQ18001 Human 4851 Details Get a Quote
NOTCH1 Knockout HeLa Cell Line EDJ-KQ18299 Human 4851 Details Get a Quote
NOTCH1 Knockout HCT 116 Cell Line EDJ-KQ18733 Human 4851 Details Get a Quote
NOTCH1 (p.D2185=) Point Mutation in HAP1 Cell Line EDC03335 Human 4851 Details Get a Quote
NOTCH1 (p.G1788S) Point Mutation in HAP1 Cell Line EDC03336 Human 4851 Details Get a Quote
NOTCH1 (p.D1698=) Point Mutation in HAP1 Cell Line EDC03337 Human 4851 Details Get a Quote
NOTCH1 (p.N755=) Point Mutation in HAP1 Cell Line EDC03338 Human 4851 Details Get a Quote
NOTCH1 (p.P668A) Point Mutation in HAP1 Cell Line EDC03339 Human 4851 Details Get a Quote
NOTCH1 (p.N104=) Point Mutation in HAP1 Cell Line EDC03340 Human 4851 Details Get a Quote
Displaying Records 1 To 10 Of 10 Records
Contact Us
*
*
*
*
How did you hear about us: